Jan Wehkamp

Company: Janssen Pharmaceuticals, Johnson & Johnson

Job title: Vice President & Gastroenterology Disease Area Stronghold Lead, Immunology

Seminars:

Unleashing Synergy: The Power of Combination Therapies to Tackle Treatment Failure 12:00 pm

Optimizing patient stratification to aid in identifying the right combination therapies for IBD patients who have not responded well to single treatments What is necessary for biomarkers to help in identifying which combination therapies are most likely to be effective for individual IBD patients? How can precision medicine assist in optimizing the balance between effectiveness…Read more

day: Conference Day One